US 8618080
Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
granted A61KA61K31/16A61K31/221
Quick answer
US patent 8618080 (Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines) held by OM PHARMA expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OM PHARMA
- Grant date
- Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/16, A61K31/221, A61K31/661, A61K31/6615